Company intelligence / Profile preview

Connect2Trials

California, United States

Ownership: Private
Development stage: Other

Overview

Connect2Trials provides a digital patient engagement and retention platform for clinical trials, focused on improving trial completion through community, peer-to-peer interactions, and incentives; it is supported and financed by Oncology Pharma for commercialization and partnerships with CROs, advocacy groups, and pharma companies.[1][4][6]

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Oncology Pharma (strategic financing and commercialization support partner)[1][4]Ribera Solutions (original developer of Connect2Med platform, technology assigned to Connect2Trials)[1][4]Discussions with top CROs, advocacy groups, and pharma companies for pilot deployments (names not disclosed)[1][4]

Beyond the preview

Go deeper on Connect2Trials.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Connect2Trials.

Explore the full profile